
Huna-ai
We are committed to making early cancer detection.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor | €0.0 | round |
* | $1.5m | Seed | |
Total Funding | 000k |
Related Content
HUNA is a pioneering company specializing in AI-driven health solutions, focusing on early cancer detection through blood tests. The company serves a diverse range of clients including hospitals, clinics, laboratories, and insurance companies. Operating in the healthcare and biotechnology market, HUNA leverages state-of-the-art artificial intelligence algorithms to analyze blood exams, aiming to make early cancer detection faster, cheaper, and more accessible. The business model revolves around providing these AI-based diagnostic tools to healthcare providers and institutions, generating revenue through service fees and partnerships. HUNA has garnered significant recognition, including a pre-seed funding round of 850K USD from three major venture capital firms and selection into the prestigious HARENA Innovation Hub in Brazil. The company's technology has been validated by health experts and academic institutions, and its research has been published in reputable journals like Nature. HUNA's mission is to harness technology to support humanity, offering innovative solutions to long-standing health problems.
Keywords: AI-driven, cancer detection, blood tests, healthcare, biotechnology, hospitals, clinics, laboratories, insurance, innovation.